BRNS
Barinthus Biotherapeutics Plc
NASDAQ · Healthcare · Biotechnology · GB
$0.74
−2.49%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- -$0.27
- Revenue estimate
- $216.9K
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.26
- EPS estimate
- -$0.28
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +27.5%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.28 | -$0.26 | Beat 7.14% | — |
| Apr 30, 2026 | -$0.36 | -$0.14 | Beat 61.11% | — |
| Mar 13, 2026 | -$0.34 | -$0.27 | Beat 21.74% | — |
| Nov 7, 2025 | -$0.45 | -$0.36 | Beat 20.00% | — |
| Aug 7, 2025 | -$0.29 | -$0.52 | Miss -79.31% | — |
| May 7, 2025 | -$0.34 | -$0.49 | Miss -44.12% | — |
| Mar 20, 2025 | -$0.50 | -$0.51 | Miss -2.00% | -$9.2M |
| Mar 20, 2024 | -$0.55 | -$0.45 | Beat 18.18% | $5.4M |
| Nov 9, 2023 | -$0.62 | -$0.37 | Beat 40.32% | — |
| Aug 10, 2023 | -$0.59 | -$0.62 | Miss -5.08% | $334.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026